Dr
Louise
Baker

European Patent Attorney

Birmingham Office

Chemistry

Telephone. +44(0) 121 265 7930
Email. [email protected]

Experience

Louise joined HGF in September 2018 and qualified as a European Patent Attorney in July 2022.

Louise's background and qualifications are in chemistry. She graduated in 2013 with a First Class MSci honours degree in Chemistry and obtained her PhD in 2018, both from the University of Birmingham. Louise's PhD research involved the de novo design of peptide architectures for use as imaging agents.

Alongside her undergraduate studies, Louise also worked in industry, undertaking two summer placements in the Research and Development team at Scott Bader.

During her PhD she spent two months working with collaborators in San Sebastian. This work was presented at several international conferences and resulted in a number of publications.

Following the completion of her PhD, Louise completed two research fellow posts at the University of Birmingham, the first in the School of Chemistry and the second in the Institute of Microbiology and Infection. Here she explored topical treatments for age-related macular degeneration, presenting her work at the ARVO Annual Meeting in Hawaii. Alongside this project, she assisted in researching the development of smart coatings for implant materials.

Qualifications

Patent Attorney

Europe


MSCI

MSci, Chemistry, 2013

PHD

PhD, Chemistry, 2017

POSTGRADUATE DIPLOMA OR CERTIFICATE

PG Cert, Intellectual Property Law, 2019

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Dot Inc, the accessible future and more: health tech highlights coming to CES 2023

The countdown is on for CES 2023. Taking place in Las Vegas in the first week of January each year, CES sets the global stage for innovation in the tech …

Read article

Can AI replace patent attorneys?

OpenAI recently released a dialogue-based AI chatbot called ChatGPT, which is free for anyone to try out. You can try it here (https://chat.openai.com/chat). It’s been shown that it can set, …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.